JP2020533408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533408A5 JP2020533408A5 JP2020535321A JP2020535321A JP2020533408A5 JP 2020533408 A5 JP2020533408 A5 JP 2020533408A5 JP 2020535321 A JP2020535321 A JP 2020535321A JP 2020535321 A JP2020535321 A JP 2020535321A JP 2020533408 A5 JP2020533408 A5 JP 2020533408A5
- Authority
- JP
- Japan
- Prior art keywords
- bacteriophage
- seq
- genomic sequence
- sequence represented
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241001515965 unidentified phage Species 0.000 claims 129
- 230000002101 lytic effect Effects 0.000 claims 39
- 241000588747 Klebsiella pneumoniae Species 0.000 claims 35
- 208000015181 infectious disease Diseases 0.000 claims 30
- 230000001580 bacterial effect Effects 0.000 claims 29
- 241000588915 Klebsiella aerogenes Species 0.000 claims 19
- 229940092559 enterobacter aerogenes Drugs 0.000 claims 19
- 239000000203 mixture Substances 0.000 claims 17
- 241000588914 Enterobacter Species 0.000 claims 15
- 241000894006 Bacteria Species 0.000 claims 10
- 241000408187 Theagenes Species 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000012472 biological sample Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 3
- 210000000936 intestine Anatomy 0.000 claims 3
- 241000588748 Klebsiella Species 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 239000006166 lysate Substances 0.000 claims 1
- 230000001320 lysogenic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762555790P | 2017-09-08 | 2017-09-08 | |
| US62/555,790 | 2017-09-08 | ||
| PCT/IB2018/001128 WO2019048930A2 (en) | 2017-09-08 | 2018-09-07 | BACTERIOPHAGE OF MODULATION OF INFLAMMATORY INTESTINAL DISEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533408A JP2020533408A (ja) | 2020-11-19 |
| JP2020533408A5 true JP2020533408A5 (enExample) | 2021-10-07 |
Family
ID=64316588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020535321A Withdrawn JP2020533408A (ja) | 2017-09-08 | 2018-09-07 | 炎症性腸疾患を制御するためのバクテリオファージ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220031776A1 (enExample) |
| EP (2) | EP3678639B1 (enExample) |
| JP (1) | JP2020533408A (enExample) |
| CN (1) | CN111801107A (enExample) |
| AU (1) | AU2018330848A1 (enExample) |
| CA (1) | CA3074406A1 (enExample) |
| WO (1) | WO2019048930A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112469426B (zh) * | 2018-05-23 | 2025-07-11 | 布莱阿姆青年大学 | 噬菌体组合物和试剂盒及相关方法 |
| US11986502B2 (en) | 2018-05-23 | 2024-05-21 | Optium, LLC | Bacteriophage compositions and kits and related methods |
| CA3131316A1 (en) | 2019-03-07 | 2020-09-10 | Keio University | Bacteriophage for modulating inflammatory bowel disease |
| US20240075084A1 (en) * | 2021-01-21 | 2024-03-07 | Biomx Ltd. | Klebsiella bacteriophage and uses thereof |
| US20250281553A1 (en) * | 2021-04-22 | 2025-09-11 | Ferring B.V. | Bacteriophage therapy against adherent-invasive escherichia coli |
| CN115558650B (zh) * | 2022-10-09 | 2023-05-30 | 优宜邦生物科技(上海)有限公司 | 一种宽宿主谱变栖克雷伯氏菌噬菌体及其应用和制剂 |
| CN118318913A (zh) * | 2024-05-09 | 2024-07-12 | 江苏省农业科学院 | 一种含有噬菌体的新型饲料添加剂及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| EP2799063A1 (en) * | 2013-04-30 | 2014-11-05 | Ferring B.V. | Bacteriophage therapy |
| CN106754745B (zh) * | 2016-11-29 | 2020-07-14 | 江苏省农业科学院 | 一种肺炎克雷伯氏菌噬菌体及其应用 |
-
2018
- 2018-09-07 CA CA3074406A patent/CA3074406A1/en not_active Abandoned
- 2018-09-07 AU AU2018330848A patent/AU2018330848A1/en not_active Abandoned
- 2018-09-07 CN CN201880071574.4A patent/CN111801107A/zh active Pending
- 2018-09-07 JP JP2020535321A patent/JP2020533408A/ja not_active Withdrawn
- 2018-09-07 US US16/644,641 patent/US20220031776A1/en not_active Abandoned
- 2018-09-07 EP EP18803755.0A patent/EP3678639B1/en active Active
- 2018-09-07 WO PCT/IB2018/001128 patent/WO2019048930A2/en not_active Ceased
- 2018-09-07 EP EP21198738.3A patent/EP4032526A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533408A5 (enExample) | ||
| Yuan et al. | Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii | |
| Strathdee et al. | Phage therapy: From biological mechanisms to future directions | |
| Dalmasso et al. | Three new Escherichia coli phages from the human gut show promising potential for phage therapy | |
| Abeles et al. | Molecular bases and role of viruses in the human microbiome | |
| Knezevic et al. | Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa | |
| Bhargava et al. | Phage therapeutics: from promises to practices and prospectives | |
| Feng et al. | JD419, a Staphylococcus aureus phage with a unique morphology and broad host range | |
| JP2019108378A5 (enExample) | ||
| Cochrane et al. | Complete genome sequences and analysis of the Fusobacterium nucleatum subspecies animalis 7-1 bacteriophage ɸFunu1 and ɸFunu2 | |
| Kim et al. | Complete genome of Staphylococcus aureus phage SA11 | |
| Cui et al. | Characterization and complete genome of the virulent Myoviridae phage JD007 active against a variety of Staphylococcus aureus isolates from different hospitals in Shanghai, China | |
| Dallal et al. | Phage therapy as an approach to control Salmonella enterica serotype Enteritidis infection in mice | |
| Beutin et al. | Shiga toxin-producing Escherichia coli strains from cattle as a source of the Stx2a bacteriophages present in enteroaggregative Escherichia coli O104: H4 strains | |
| Pacífico et al. | Natural occurrence of Escherichia coli-infecting bacteriophages in clinical samples | |
| Viscardi et al. | Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC) | |
| Ahiwale et al. | Isolation and characterization of a rare waterborne lytic phage of Salmonella enterica serovar Paratyphi B | |
| Bakhtiyari et al. | Strategies to overcome antimicrobial resistance in nosocomial infections, a review and update | |
| Chen et al. | Isolation and genomic characterization of PA-5, a novel virulent bacteriophage against Enterobacter hormaechei | |
| Arumugam et al. | Analysis of susceptibility patterns of Pseudomonas aeruginosa and isolation, characterization of lytic bacteriophages targeting multi drug resistant Pseudomonas aeruginosa | |
| Esmael et al. | Biocontrol of Acinetobacter baumannii-S-MH using bacteriophages isolated from sewage water | |
| Biswas et al. | Beyond antibiotics: exploring the potential of bacteriophages and phage therapy | |
| Xing et al. | Complete genome sequence of a novel multidrug-resistant Klebsiella pneumoniae phage, vB_Kpn_IME260 | |
| Hardany et al. | Phage therapy against MDR and XDR Salmonella enterica serovars at Basrah Province, Iraq | |
| Sheng et al. | Characteristics of antibiotic resistance and plasmid conjugative transfer of IncI1 and IncN plasmid positive Salmonella. |